Abstract:

Neonatal convulsion is one of the most common emergency neurological diseases of the newborn period. The frequency is to be 1.5-3 in 1000 live births. It is known that the congestion threshold is lower due to the immature of neurons in newborns and the differences in neurotransmitters. The most common cause in the ethology in newborn convulsions is hypoxic ischemic encephalopathy, and other causes may vary according to the level of development of the country. Convulsions are classified in four different types according to clinical findings. The most common type is the subtle (unidentified) type of infection. The other types are clonic, tonic and myoclonic attacks. Non-epileptic paroxysmal movements, which can be frequently seen in the newborn period, should not be mixed with the stroke. The most common non-epileptic paroxysmal movements are jitterness, sleep myoclony, and hyperplexity. If possible, the baby diagnosed convulsion in the newborn period should be monitored with continuous video EEG. If the baby is quickly assessed and acute metabolic disorder is detected, treatment should be given, otherwise treatment with anti-inflammatory drugs should be planned. There are many studies on anti-inflammatory drugs, but phenobarbital is still recommended in the first stage of treatment. In the second stage, levetirasetam and phenitoin are commonly used anti-inflammatory drugs. The purpose of treatment should not only stop acute symptomatic attacks, but also reduce brain damage, minimizing the epilepsy and neurological adverse effects that may then develop.

Keywords: